AxoGen Common Stock Net 2010-2025 | AXGN
AxoGen common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
| AxoGen Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| AxoGen Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | $0 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $0 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.572B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $176.182B | 21.31 |
| Intuitive Surgical (ISRG) | United States | $173.273B | 71.82 |
| IDEXX Laboratories (IDXX) | United States | $54.910B | 56.85 |
| Edwards Lifesciences (EW) | United States | $46.981B | 31.16 |
| Alcon (ALC) | Switzerland | $43.317B | 29.27 |
| IQVIA Holdings (IQV) | United States | $31.068B | 17.56 |
| DexCom (DXCM) | United States | $29.902B | 44.85 |
| Mettler-Toledo (MTD) | United States | $25.376B | 30.12 |
| STERIS (STE) | Ireland | $22.471B | 24.75 |
| Waters (WAT) | United States | $16.995B | 23.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.379B | 0.00 |
| Hologic (HOLX) | United States | $15.104B | 16.36 |
| Sysmex ADR (SSMXY) | Japan | $10.577B | 30.00 |
| Penumbra (PEN) | United States | $9.375B | 68.49 |
| Masimo (MASI) | United States | $8.744B | 32.25 |
| Globus Medical (GMED) | United States | $7.260B | 17.30 |
| Teleflex (TFX) | United States | $5.129B | 8.28 |
| Glaukos (GKOS) | United States | $5.000B | 0.00 |
| TransMedics (TMDX) | United States | $4.381B | 66.58 |
| Integer Holdings (ITGR) | United States | $3.743B | 18.68 |
| PROCEPT BioRobotics (PRCT) | United States | $2.744B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.332B | 13.88 |
| Alphatec Holdings (ATEC) | United States | $2.201B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.946B | 22.32 |
| Veracyte (VCYT) | United States | $1.905B | 26.73 |
| Elekta AB (EKTAY) | Sweden | $1.837B | 16.52 |
| Artivion (AORT) | United States | $1.369B | 128.24 |
| Tandem Diabetes Care (TNDM) | United States | $1.027B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.014B | 0.00 |
| OPKO Health (OPK) | United States | $1.008B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.979B | 5.61 |
| IRadimed (IRMD) | United States | $0.899B | 43.64 |
| SiBone (SIBN) | United States | $0.763B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.714B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.520B | 8.09 |
| OrthoPediatrics (KIDS) | United States | $0.499B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.488B | 4.21 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.425B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.421B | 9.78 |
| Pacific Biosciences Of California (PACB) | United States | $0.417B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.353B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.352B | 0.00 |
| RxSight (RXST) | United States | $0.322B | 0.00 |
| Neuronetics (STIM) | United States | $0.308B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.293B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.256B | 0.00 |
| 908 Devices (MASS) | United States | $0.234B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 15.22 |
| CVRx (CVRX) | United States | $0.197B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.195B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.179B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.167B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.153B | 0.00 |
| Accuray (ARAY) | United States | $0.145B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.124B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.121B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.110B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.096B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.093B | 0.00 |
| Hyperfine (HYPR) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.090B | 55.00 |
| InspireMD (NSPR) | United States | $0.082B | 0.00 |
| Spectral AI (MDAI) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.25 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |